Nasal High Flow Treatment for COPD Exercise Tolerance
Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
- Age
- 18 – 100
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 45 (estimated)
- Sponsor
- University of Miami · Other
This trial is looking for adults with COPD who can walk without help. Participants will test a treatment using nasal high flow oxygen to see how it affects their ability to walk for six minutes and their breathing discomfort.
You may be able to join if
- I am at least 18 years old
- I have been diagnosed with COPD
- I can walk without assistance
- I can provide consent
- I am using no more than 4 liters of oxygen per minute or none at all
You may not be able to join if
- I am pregnant
- I am on bedrest
- I cannot consent or cooperate with the study
- I use more than 4 liters of oxygen per minute or need ventilation during the day
- I have an unstable heart rate or blood pressure
- I have metal implants in my chest area
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThis study aims to assess whether to describe the effects of the administration of nasal high flow (NHF) at 70 liters per minute (L/min) in a 6-Minute Walk Test (6-MWT) among Chronic Obstructive Pulmonary Disease (COPD) patients and to characterize the association between self-reported dyspnea with and without NHF at 70 L/min following a 6-MWT.
Loading trial locations…